Sjogren’s syndrome: evolving therapies

By Fox Robert I  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 247-254

Informa Healthcare

Access to resources Recommend Favorite

Anti-CD20 Antibody in Primary Sjogren’s Syndrome Management

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 6, 2014-06 ,pp. : 535-541

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Treatment Strategies and Potential Therapeutic Targets in Primary Sjogren's Syndrome

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. : 10-19

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse Models of Primary Sjogren’s Syndrome

By  

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2350-2364

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroimmune Aspects of Sjogren’s Syndrome: Role of VIP/VPAC System in Immune and Salivary Gland Epithelial Cell Function

By  

Current Pharmaceutical Design, Vol. 20, Iss. 29, 2014-09 ,pp. : 4760-4765

Bentham Science Publishers

Access to resources Recommend Favorite